PFBT
PRME icon

Parkside Financial Bank & Trust’s Prime Medicine PRME Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05K Hold
285
– – ﹤0.01% 2388
2026
Q1 		$992 Hold
285
– – ﹤0.01% 2363
2025
Q4 		$989 Hold
285
– – ﹤0.01% 2347
2025
Q3 		$1.58K Hold
285
– – ﹤0.01% 2106
2025
Q2 		$700 Buy
+285
New +$439 ﹤0.01% 2383

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Parkside Financial Bank & Trust's PRME Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Prime Medicine (PRME) position steady in Q2 2026 at 285 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Parkside Financial Bank & Trust first reported a position in PRME in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.58K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Parkside Financial Bank & Trust held 285 shares of Prime Medicine worth $1.05K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Prime Medicine share count unchanged in Q2 2026.
  • Prime Medicine made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2388 holding.
  • Parkside Financial Bank & Trust first reported a position in Prime Medicine in Q2 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Prime Medicine position peaked at $1.58K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.